The DOI matches its Crossref record; 227 of the 227 references it cites were found in a registry or an index.
Gastroenteropancreatic Neuroendocrine Tumors
Open accessAbstract
Neuroendocrine tumors (NETs) are heterogeneous malignancies arising from the diffuse neuroendocrine system. They frequently originate in the gastroenteropancreatic (GEP) tract and the bronchopulmonary tree, and their incidence has steadily increased in the last 3 decades. Fundamental biologic and genomic differences underlie the clinical heterogeneity of NETs, and distinct molecular features characterize NETs of different grades and different primary sites. Although surgery remains the cornerstone of treatment for localized tumors, systemic treatment options for patients with metastatic NETs have expanded considerably. Somatostatin analogs have demonstrated both antisecretory and antitumor efficacy. Peptide receptor radionuclide therapy with lutetium‐177 dotatate ( 177 Lu‐DOTATATE) has been approved for advanced GEP‐NETs. The antitumor activity of everolimus has been demonstrated across a wide spectrum of NETs, and the antiangiogenic agent sunitinib has been approved for pancreatic NETs (pNETs). Chemotherapy with temozolomide and capecitabine has recently demonstrated an unprecedented prolongation of progression‐free survival in a randomized trial of pNETs. Multiple retrospective series have reported the efficacy of liver‐directed therapies both for palliating symptoms of hormone excess and for controlling tumor growth. Telotristat, an oral inhibitor of tryptophan hydroxylase, has been shown to reduce diarrhea in patients with carcinoid syndrome. Defining the therapeutic algorithm and identifying biomarkers predictive of response to treatments are among the main priorities for the next decade of research in the NET field.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Yao, J. C., Hassan, M., Phan, A., Dagohoy, C., Leary, C., Mares, J. E., Abdalla, E. K., Fleming, J. B., Vauthey, J.-N., Rashid, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.4377 · Cited by 4,510
Dasari, A., Shen, C., Halperin, D., Zhao, B., Zhou, S., Xu, Y., Shih, T., & Yao, J. C. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.0589 · Cited by 3,447
Phase 3 Trial of 177 Lu-Dotatate for Midgut Neuroendocrine Tumors
Strosberg, J., El-Haddad, G., Wolin, E., Hendifar, A., Yao, J., Chasen, B., Mittra, E., Kunz, P. L., Kulke, M. H., Jacene, H., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1607427 · Cited by 3,308
Self-citationEverolimus for Advanced Pancreatic Neuroendocrine Tumors
Yao, J. C., Shah, M. H., Ito, T., Bohas, C. L., Wolin, E. M., Van Cutsem, E., Hobday, T. J., Okusaka, T., Capdevila, J., de Vries, E. G. E., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1009290 · Cited by 2,876
Sunitinib Malate for the Treatment of Pancreatic Neuroendocrine Tumors
Raymond, E., Dahan, L., Raoul, J.-L., Bang, Y.-J., Borbath, I., Lombard-Bohas, C., Valle, J., Metrakos, P., Smith, D., Vinik, A., et al. (2011) · New England Journal of Medicine · doi:10.1056/nejmoa1003825 · Cited by 2,567
Rinke, A., Müller, H.-H., Schade-Brittinger, C., Klose, K.-J., Barth, P., Wied, M., Mayer, C., Aminossadati, B., Pape, U.-F., Bläker, M., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8510 · Cited by 2,508
Lanreotide in Metastatic Enteropancreatic Neuroendocrine Tumors
Caplin, M. E., Pavel, M., Ćwikła, J. B., Phan, A. T., Raderer, M., Sedláčková, E., Cadiot, G., Wolin, E. M., Capdevila, J., Wall, L., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1316158 · Cited by 1,935
Gastroenteropancreatic neuroendocrine tumours
Modlin, I. M., Oberg, K., Chung, D. C., Jensen, R. T., de Herder, W. W., Thakker, R. V., Caplin, M., Delle Fave, G., Kaltsas, G. A., Krenning, E. P., et al. (2008) · The Lancet Oncology · doi:10.1016/s1470-2045(07)70410-2 · Cited by 1,748
Jiao, Y., Shi, C., Edil, B. H., de Wilde, R. F., Klimstra, D. S., Maitra, A., Schulick, R. D., Tang, L. H., Wolfgang, C. L., Choti, M. A., et al. (2011) · Science · doi:10.1126/science.1200609 · Cited by 1,717
Identification of the Tuberous Sclerosis Gene TSC1 on Chromosome 9q34
Slegtenhorst, M. V., Hoogt, R. D., Hermans, C., Nellist, M., Janssen, B., Verhoef, S., Lindhout, D., Ouweland, A. V. D., Halley, D., Young, J., et al. (1997) · Science · doi:10.1126/science.277.5327.805 · Cited by 1,648
Krenning, E. P., Kwekkeboom, D. J., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Oei, H. Y., van Hagen, M., Postema, P. T. E., de Jong, M., Reubi, J. C., et al. (1993) · European Journal of Nuclear Medicine · doi:10.1007/bf00181765 · Cited by 1,564
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system
Rindi, G., Klöppel, G., Alhman, H., Caplin, M., Couvelard, A., de Herder, W. W., Erikssson, B., Falchetti, A., Falconi, M., Komminoth, P., et al. (2006) · Virchows Archiv · doi:10.1007/s00428-006-0250-1 · Cited by 1,547
Kwekkeboom, D. J., de Herder, W. W., Kam, B. L., van Eijck, C. H., van Essen, M., Kooij, P. P., Feelders, R. A., van Aken, M. O., & Krenning, E. P. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.2553 · Cited by 1,456
Falconi, M., Eriksson, B., Kaltsas, G., Bartsch, D. K., Capdevila, J., Caplin, M., Kos-Kudla, B., Kwekkeboom, D., Rindi, G., Klöppel, G., et al. (2016) · Neuroendocrinology · doi:10.1159/000443171 · Cited by 1,362
Primary Peptic Ulcerations of the Jejunum Associated with Islet Cell Tumors of the Pancreas
ZOLLINGER, R. M., & ELLISON, E. H. (1955) · Annals of Surgery · doi:10.1097/00000658-195510000-00015 · Cited by 1,326
Yao, J. C., Fazio, N., Singh, S., Buzzoni, R., Carnaghi, C., Wolin, E., Tomasek, J., Raderer, M., Lahner, H., Voi, M., et al. (2016) · The Lancet · doi:10.1016/s0140-6736(15)00817-x · Cited by 1,292
Self-citationAn analysis of 8305 cases of carcinoid tumors
Modlin, I. M., & Sandor, A. (2000) · Cancer · doi:10.1002/(sici)1097-0142(19970215)79:4<813::aid-cncr19>3.0.co;2-2 · Cited by 1,200
Klimstra, D. S., Modlin, I. R., Coppola, D., Lloyd, R. V., & Suster, S. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ec124e · Cited by 1,072
Pavel, M. E., Hainsworth, J. D., Baudin, E., Peeters, M., Hörsch, D., Winkler, R. E., Klimovsky, J., Lebwohl, D., Jehl, V., Wolin, E. M., et al. (2011) · The Lancet · doi:10.1016/s0140-6736(11)61742-x · Cited by 1,058
Multiple endocrine neoplasia type 1 gene maps to chromosome 11 and is lost in insulinoma
Larsson, C., Skogseid, B., Öberg, K., Nakamura, Y., & Nordenskjöld, M. (1988) · Nature · doi:10.1038/332085a0 · Cited by 1,028
Sorbye, H., Welin, S., Langer, S. W., Vestermark, L. W., Holt, N., Osterlund, P., Dueland, S., Hofsli, E., Guren, M. G., Ohrling, K., et al. (2013) · Annals of Oncology · doi:10.1093/annonc/mds276 · Cited by 1,027
Whole-genome landscape of pancreatic neuroendocrine tumours
Initiative, A. P. C. G., Scarpa, A., Chang, D. K., Nones, K., Corbo, V., Patch, A.-M., Bailey, P., Lawlor, R. T., Johns, A. L., Miller, D. K., et al. (2017) · Nature · doi:10.1038/nature21063 · Cited by 999
Moertel, C. G., Lefkopoulo, M., Lipsitz, S., Hahn, R. G., & Klaassen, D. (1992) · New England Journal of Medicine · doi:10.1056/nejm199202203260804 · Cited by 976
Rindi, G., Klöppel, G., Couvelard, A., Komminoth, P., Körner, M., Lopes, J. M., McNicol, A.-M., Nilsson, O., Perren, A., Scarpa, A., et al. (2007) · Virchows Archiv · doi:10.1007/s00428-007-0452-1 · Cited by 955
Halfdanarson, T. R., Rabe, K. G., Rubin, J., & Petersen, G. M. (2008) · Annals of Oncology · doi:10.1093/annonc/mdn351 · Cited by 892
THE CLASSIFICATION OF CARCINOID TUMOURS
WILLIAMS, E. (1963) · The Lancet · doi:10.1016/s0140-6736(63)90951-6 · Cited by 885
Functioning insulinoma—incidence, recurrence, and long-term survival of patients: a 60-year study.
SERVICE, F. J., McMAHON, M. M., O'BRIEN, P. C., & BALLARD, D. J. (1991) · Mayo Clinic Proceedings · doi:10.1016/s0025-6196(12)62083-7 · Cited by 883
Genetic aspects of adenomatosis of endocrine glands
Wermer, P. (1954) · The American Journal of Medicine · doi:10.1016/0002-9343(54)90353-8 · Cited by 860
Treatment of the Malignant Carcinoid Syndrome
Kvols, L. K., Moertel, C. G., O'Connell, M. J., Schutt, A. J., Rubin, J., & Hahn, R. G. (1986) · New England Journal of Medicine · doi:10.1056/nejm198609113151102 · Cited by 849
Moertel, C. G., Kvols, L. K., O'Connell, M. J., & Rubin, J. (1991) · Cancer · doi:10.1002/1097-0142(19910715)68:2<227::aid-cncr2820680202>3.0.co;2-i · Cited by 840
The Chromogranin–Secretogranin Family
Taupenot, L., Harper, K. L., & O'Connor, D. T. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021405 · Cited by 819
Sarmiento, J. M., Heywood, G., Rubin, J., Ilstrup, D. M., Nagorney, D. M., & Que, F. G. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00230-8 · Cited by 773
Strosberg, J. R., Fine, R. L., Choi, J., Nasir, A., Coppola, D., Chen, D., Helm, J., & Kvols, L. (2011) · Cancer · doi:10.1002/cncr.25425 · Cited by 766
Self-citationThe von Hippel–Lindau tumour suppressor protein: O2 sensing and cancer
Kaelin Jr, W. G. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2502 · Cited by 726
Localization of Pancreatic Endocrine Tumors by Endoscopic Ultrasonography
Rösch, T., Lightdale, C. J., Botet, J. F., Boyce, G. A., Sivak, M. V., Yasuda, K., Heyder, N., Palazzo, L., Dancygier, H., Schusdziarra, V., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199206253262601 · Cited by 713
Lemos, M. C., & Thakker, R. V. (2008) · Human Mutation · doi:10.1002/humu.20605 · Cited by 675
ERSPAMER, V., & ASERO, B. (1952) · Nature · doi:10.1038/169800b0 · Cited by 670
Moertel, C. G., Hanley, J. A., & Johnson, L. A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198011203032101 · Cited by 659
Yao, J. C., Lombard-Bohas, C., Baudin, E., Kvols, L. K., Rougier, P., Ruszniewski, P., Hoosen, S., St. Peter, J., Haas, T., Lebwohl, D., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.24.2669 · Cited by 647
Imhof, A., Brunner, P., Marincek, N., Briel, M., Schindler, C., Rasch, H., Mäcke, H. R., Rochlitz, C., Müller-Brand, J., & Walter, M. A. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.7873 · Cited by 641
Islet cell tumor and a syndrome of refractory watery diarrhea and hypokalemia
Verner, J. V., & Morrison, A. B. (1958) · The American Journal of Medicine · doi:10.1016/0002-9343(58)90075-5 · Cited by 636
Lovejoy, C. A., Li, W., Reisenweber, S., Thongthip, S., Bruno, J., de Lange, T., De, S., Petrini, J. H. J., Sung, P. A., Jasin, M., et al. (2012) · PLoS Genetics · doi:10.1371/journal.pgen.1002772 · Cited by 629
Activity of Sunitinib in Patients With Advanced Neuroendocrine Tumors
Kulke, M. H., Lenz, H.-J., Meropol, N. J., Posey, J., Ryan, D. P., Picus, J., Bergsland, E., Stuart, K., Tye, L., Huang, X., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.9020 · Cited by 623
Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients.
Pellikka, P. A., Tajik, A. J., Khandheria, B. K., Seward, J. B., Callahan, J. A., Pitot, H. C., & Kvols, L. K. (1993) · Circulation · doi:10.1161/01.cir.87.4.1188 · Cited by 614
Brabander, T., van der Zwan, W. A., Teunissen, J. J. M., Kam, B. L. R., Feelders, R. A., de Herder, W. W., van Eijck, C. H. J., Franssen, G. J. H., Krenning, E. P., & Kwekkeboom, D. J. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-2743 · Cited by 614
Kouvaraki, M. A., Ajani, J. A., Hoff, P., Wolff, R., Evans, D. B., Lozano, R., & Yao, J. C. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.04.024 · Cited by 607
NANETS Treatment Guidelines: Well-Differentiated Neuroendocrine Tumors of the Stomach and Pancreas
Kulke, M. H., Anthony, L. B., Bushnell, D. L., de Herder, W. W., Goldsmith, S. J., Klimstra, D. S., Marx, S. J., Pasieka, J. L., Pommier, R. F., Yao, J. C., et al. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ebb168 · Cited by 574
Opportunities in somatostatin research: biological, chemical and therapeutic aspects
Weckbecker, G., Lewis, I., Albert, R., Schmid, H. A., Hoyer, D., & Bruns, C. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1255 · Cited by 559
Life history of the carcinoid tumor of the small intestine
Moertel, C. G., Sauer, W. G., Dockerty, M. B., & Baggenstoss, A. H. (1961) · Cancer · doi:10.1002/1097-0142(196109/10)14:5<901::aid-cncr2820140502>3.0.co;2-q · Cited by 555
Updated Population-Based Review of Carcinoid Tumors
Maggard, M. A., O??Connell, J. B., & Ko, C. Y. (2004) · Annals of Surgery · doi:10.1097/01.sla.0000129342.67174.67 · Cited by 552
Endocrine tumours of the pancreas
Öberg, K., & Eriksson, B. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.06.002 · Cited by 543
Boudreaux, J. P., Klimstra, D. S., Hassan, M. M., Woltering, E. A., Jensen, R. T., Goldsmith, S. J., Nutting, C., Bushnell, D. L., Caplin, M. E., & Yao, J. C. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ebb2a5 · Cited by 539
Thorson, Å., Biörck, G., Björkman, G., & Waldenström, J. (1954) · American Heart Journal · doi:10.1016/0002-8703(54)90152-0 · Cited by 536
Phase II Study of Temozolomide and Thalidomide in Patients With Metastatic Neuroendocrine Tumors
Kulke, M. H., Stuart, K., Enzinger, P. C., Ryan, D. P., Clark, J. W., Muzikansky, A., Vincitore, M., Michelini, A., & Fuchs, C. S. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.6046 · Cited by 513
Buchmann, I., Henze, M., Engelbrecht, S., Eisenhut, M., Runz, A., Schäfer, M., Schilling, T., Haufe, S., Herrmann, T., & Haberkorn, U. (2007) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-007-0450-1 · Cited by 506
Surgery to Cure the Zollinger–Ellison Syndrome
Norton, J. A., Fraker, D. L., Alexander, H. R., Venzon, D. J., Doppman, J. L., Serrano, J., Goebel, S. U., Peghini, P. L., Roy, P. K., Gibril, F., et al. (1999) · New England Journal of Medicine · doi:10.1056/nejm199908263410902 · Cited by 504
Faiss, S., Pape, U.-F., Böhmig, M., Dörffel, Y., Mansmann, U., Golder, W., Riecken, E. O., & Wiedenmann, B. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.142 · Cited by 501
Treatment of poorly differentiated neuroendocrine tumours with etoposide and cisplatin
Mitry, E., Baudin, E., Ducreux, M., Sabourin, J.-C., Rufié, P., Aparicio, T., Lasser, P., Elias, D., Duvillard, P., Schlumberger, M., et al. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690325 · Cited by 496
ENETS Consensus Guidelines Update for Gastroduodenal Neuroendocrine Neoplasms
Delle Fave, G., O''Toole, D., Sundin, A., Taal, B., Ferolla, P., Ramage, J. K., Ferone, D., Ito, T., Weber, W., Zheng-Pei, Z., et al. (2016) · Neuroendocrinology · doi:10.1159/000443168 · Cited by 495
Secretion of Chromogranin A by Peptide-Producing Endocrine Neoplasms
O'Connor, D. T., & Deftos, L. J. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605013141803 · Cited by 477
Karnofsky memorial lecture. An odyssey in the land of small tumors.
Moertel, C. G. (1987) · Journal of Clinical Oncology · doi:10.1200/jco.1987.5.10.1502 · Cited by 473
Somatostatin receptor-based imaging and therapy of gastroenteropancreatic neuroendocrine tumors
Kwekkeboom, D. J., Kam, B. L., van Essen, M., Teunissen, J. J. M., van Eijck, C. H. J., Valkema, R., de Jong, M., de Herder, W. W., & Krenning, E. P. (2010) · Endocrine-Related Cancer · doi:10.1677/erc-09-0078 · Cited by 466
Pape, U.-F., Perren, A., Niederle, B., Gross, D., Gress, T., Costa, F., Arnold, R., Denecke, T., Plöckinger, U., Salazar, R., et al. (2012) · Neuroendocrinology · doi:10.1159/000335629 · Cited by 465
Marinoni, I., Kurrer, A. S., Vassella, E., Dettmer, M., Rudolph, T., Banz, V., Hunger, F., Pasquinelli, S., Speel, E., & Perren, A. (2014) · Gastroenterology · doi:10.1053/j.gastro.2013.10.020 · Cited by 463
Hepatic resection for metastatic neuroendocrine carcinomas
Que, F. G., Nagorney, D. M., Batts, K. P., Linz, L. J., & Kvols, L. K. (1995) · The American Journal of Surgery · doi:10.1016/s0002-9610(99)80107-x · Cited by 462
TNM Staging of Neoplasms of the Endocrine Pancreas: Results From a Large International Cohort Study
Rindi, G., Falconi, M., Klersy, C., Albarello, L., Boninsegna, L., Buchler, M. W., Capella, C., Caplin, M., Couvelard, A., Doglioni, C., et al. (2012) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djs208 · Cited by 452
Paulsen, S. R., Huprich, J. E., Fletcher, J. G., Booya, F., Young, B. M., Fidler, J. L., Johnson, C. D., Barlow, J. M., & Earnest, F. (2006) · RadioGraphics · doi:10.1148/rg.263055162 · Cited by 451
Multiple endocrine neoplasia type 1 (MEN1) and type 4 (MEN4)
Thakker, R. V. (2013) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2013.08.002 · Cited by 448
Valkema, R., de Jong, M., Bakker, W. H., Breeman, W. A. P., Kooij, P. P. M., Lugtenburg, P. J., de Jong, F. H., Christiansen, A., Kam, B. L. R., de Herder, W. W., et al. (2002) · Seminars in Nuclear Medicine · doi:10.1053/snuc/2002.31025 · Cited by 435
Gastric Carcinoids and Neuroendocrine Carcinomas: Pathogenesis, Pathology, and Behavior
Rindi, G., Bordi, C., Rappel, S., La Rosa, S., Stolte, M., & Solcia, E. (1996) · World Journal of Surgery · doi:10.1007/s002689900026 · Cited by 433
Surgery of urethral stricture.
Attwater, H. L. (1948) · PubMed · Cited by 429
Carcinoid Tumor of the Appendix: Treatment and Prognosis
Moertel, C. G., Weiland, L. H., Nagorney, D. M., & Dockerty, M. B. (1987) · New England Journal of Medicine · doi:10.1056/nejm198712313172704 · Cited by 427
Pancreatic involvement in von Hippel–Lindau disease
Hammel, P. R., Vilgrain, V., Terris, B., Penfornis, A., Sauvanet, A., Correas, J., Chauveau, D., Balian, A., Beigelman, C., O'Toole, D., et al. (2000) · Gastroenterology · doi:10.1053/gast.2000.18143 · Cited by 426
Pancreatic tumors: comparison of dual-phase helical CT and endoscopic sonography.
Legmann, P., Vignaux, O., Dousset, B., Baraza, A. J., Palazzo, L., Dumontier, I., Coste, J., Louvel, A., Roseau, G., Couturier, D., et al. (1998) · American Journal of Roentgenology · doi:10.2214/ajr.170.5.9574609 · Cited by 425
Kennedy, A. S., Dezarn, W. A., McNeillie, P., Coldwell, D., Nutting, C., Carter, D., Murthy, R., Rose, S., Warner, R. R. P., Liu, D., et al. (2008) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e31815e4557 · Cited by 424
Krenning, E. P., Bakker, W., Kooij, P. P. M., Breeman, W. A., Oei, H. Y., de Jong, M., Reubi, J. C., Visser, T. J., Bruns, C., & Kwekkeboom, D. J. (1992) · PubMed · Cited by 420
Yao, J. C., Phan, A., Hoff, P. M., Chen, H. X., Charnsangavej, C., Yeung, S.-C. J., Hess, K., Ng, C., Abbruzzese, J. L., & Ajani, J. A. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.13.6374 · Cited by 414
Ito, T., Igarashi, H., Nakamura, K., Sasano, H., Okusaka, T., Takano, K., Komoto, I., Tanaka, M., Imamura, M., Jensen, R. T., et al. (2015) · Journal of Gastroenterology · doi:10.1007/s00535-014-0934-2 · Cited by 405
Rubin, J., Ajani, J., Schirmer, W., Venook, A. P., Bukowski, R., Pommier, R., Saltz, L., Dandona, P., & Anthony, L. (1999) · Journal of Clinical Oncology · doi:10.1200/jco.1999.17.2.600 · Cited by 389
Dromain, C., de Baere, T., Lumbroso, J., Caillet, H., Laplanche, A., Boige, V., Ducreux, M., Duvillard, P., Elias, D., Schlumberger, M., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.01.013 · Cited by 389
Rinke, A., Wittenberg, M., Schade-Brittinger, C., Aminossadati, B., Ronicke, E., Gress, T. M., Müller, H.-H., Arnold, R., & for the PROMID Study Group (2017) · Neuroendocrinology · doi:10.1159/000443612 · Cited by 377
Howe, J. R., Cardona, K., Fraker, D. L., Kebebew, E., Untch, B. R., Wang, Y.-Z., Law, C. H., Liu, E. H., Kim, M. K., Menda, Y., et al. (2017) · Pancreas · doi:10.1097/mpa.0000000000000846 · Cited by 376
Self-citationPancreatic endocrine neoplasms: epidemiology and prognosis of pancreatic endocrine tumors
Halfdanarson, T. R., Rubin, J., Farnell, M. B., Grant, C. S., & Petersen, G. M. (2008) · Endocrine Related Cancer · doi:10.1677/erc-07-0221 · Cited by 372
Somatic mutation of CDKN1B in small intestine neuroendocrine tumors
Francis, J. M., Kiezun, A., Ramos, A. H., Serra, S., Pedamallu, C. S., Qian, Z. R., Banck, M. S., Kanwar, R., Kulkarni, A. A., Karpathakis, A., et al. (2013) · Nature Genetics · doi:10.1038/ng.2821 · Cited by 369
Liver disease induced by radioembolization of liver tumors: Description and possible risk factors
Sangro, B., Gil‐Alzugaray, B., Rodriguez, J., Sola, I., Martinez‐Cuesta, A., Viudez, A., Chopitea, A., Iñarrairaegui, M., Arbizu, J., & Bilbao, J. I. (2008) · Cancer · doi:10.1002/cncr.23339 · Cited by 369
Incidence trends and risk factors of carcinoid tumors: A nationwide epidemiologic study from Sweden
Hemminki, K., & Li, X. (2001) · Cancer · doi:10.1002/1097-0142(20011015)92:8<2204::aid-cncr1564>3.0.co;2-r · Cited by 363
Appropriate Use Criteria for Somatostatin Receptor PET Imaging in Neuroendocrine Tumors
Hope, T. A., Bergsland, E. K., Bozkurt, M. F., Graham, M., Heaney, A. P., Herrmann, K., Howe, J. R., Kulke, M. H., Kunz, P. L., Mailman, J., et al. (2018) · Journal of Nuclear Medicine · doi:10.2967/jnumed.117.202275 · Cited by 363
Self-citationSun, W., Lipsitz, S., Catalano, P., Mailliard, J. A., & Haller, D. G. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.03.616 · Cited by 357
Sadowski, S. M., Neychev, V., Millo, C., Shih, J., Nilubol, N., Herscovitch, P., Pacak, K., Marx, S. J., & Kebebew, E. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2015.64.0987 · Cited by 353
A Glucagon-Secreting Alpha-Cell Carcinoma of the Pancreas
McGavran, M. H., Unger, R. H., Recant, L., Polk, H. C., Kilo, C., & Levin, M. E. (1966) · New England Journal of Medicine · doi:10.1056/nejm196606232742503 · Cited by 352
Yang, Z., Tang, L. H., & Klimstra, D. S. (2011) · American Journal of Surgical Pathology · doi:10.1097/pas.0b013e31821a0696 · Cited by 332
Papotti, M., Bongiovanni, M., Volante, M., Allìa, E., Landolfi, S., Helboe, L., Schindler, M., Cole, S., & Bussolati, G. (2002) · Virchows Archiv · doi:10.1007/s00428-002-0609-x · Cited by 330
ENETS Consensus Guidelines Update for Colorectal Neuroendocrine Neoplasms
Ramage, J. K., De Herder, W. W., Delle Fave, G., Ferolla, P., Ferone, D., Ito, T., Ruszniewski, P., Sundin, A., Weber, W., Zheng-Pei, Z., et al. (2016) · Neuroendocrinology · doi:10.1159/000443166 · Cited by 328
Are G3 ENETS neuroendocrine neoplasms heterogeneous?
Vélayoudom-Céphise, F.-L., Duvillard, P., Foucan, L., Hadoux, J., Chougnet, C. N., Leboulleux, S., Malka, D., Guigay, J., Goere, D., Debaere, T., et al. (2013) · Endocrine-Related Cancer · doi:10.1530/erc-13-0027 · Cited by 325
The genomic landscape of small intestine neuroendocrine tumors
Banck, M. S., Kanwar, R., Kulkarni, A. A., Boora, G. K., Metge, F., Kipp, B. R., Zhang, L., Thorland, E. C., Minn, K. T., Tentu, R., et al. (2013) · Journal of Clinical Investigation · doi:10.1172/jci67963 · Cited by 324
The Glucagonoma Syndrome Clinical and Pathologic Features in 21 Patients
Wermers, R. A., Fatourechi, V., Wynne, A. G., Kvols, L. K., & Lloyd, R. V. (1996) · Medicine · doi:10.1097/00005792-199603000-00002 · Cited by 322
Partelli, S., Bartsch, D. K., Capdevila, J., Chen, J., Knigge, U., Niederle, B., van Dijkum, E. J. M. N., Pape, U.-F., Pascher, A., Ramage, J. K., et al. (2017) · Neuroendocrinology · doi:10.1159/000464292 · Cited by 316
Caplin, M. E., Buscombe, J. R., Hilson, A. J., Jones, A. L., Watkinson, A. F., & Burroughs, A. K. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02286-7 · Cited by 309
90Y-Edotreotide for Metastatic Carcinoid Refractory to Octreotide
Bushnell, D. L., O'Dorisio, T. M., O'Dorisio, M. S., Menda, Y., Hicks, R. J., Van Cutsem, E., Baulieu, J.-L., Borson-Chazot, F., Anthony, L., Benson, A. B., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.22.8585 · Cited by 306
Telotristat Ethyl, a Tryptophan Hydroxylase Inhibitor for the Treatment of Carcinoid Syndrome
Kulke, M. H., Hörsch, D., Caplin, M. E., Anthony, L. B., Bergsland, E., Öberg, K., Welin, S., Warner, R. R. P., Lombard-Bohas, C., Kunz, P. L., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.69.2780 · Cited by 303
Caplin, M., Sundin, A., Nillson, O., Baum, R. P., Klose, K. J., Kelestimur, F., Plöckinger, U., Papotti, M., Salazar, R., & Pascher, A. (2012) · Neuroendocrinology · doi:10.1159/000335594 · Cited by 301
Jann, H., Roll, S., Couvelard, A., Hentic, O., Pavel, M., Müller‐Nordhorn, J., Koch, M., Röcken, C., Rindi, G., Ruszniewski, P., et al. (2011) · Cancer · doi:10.1002/cncr.25855 · Cited by 289
Bajetta, E., Ferrari, L., Martinetti, A., Celio, L., Procopio, G., Artale, S., Zilembo, N., Di Bartolomeo, M., Seregni, E., & Bombardieri, E. (1999) · Cancer · doi:10.1002/(sici)1097-0142(19990901)86:5<858::aid-cncr23>3.0.co;2-8 · Cited by 289
Expression of vascular endothelial growth factor in digestive neuroendocrine tumours
Terris, Scoazec, Rubbia, Bregeaud, Pepper, Ruszniewski, Belghiti, FLÉjou, & Degott (1998) · Histopathology · doi:10.1046/j.1365-2559.1998.00321.x · Cited by 279
Anthony, L. B., Strosberg, J. R., Klimstra, D. S., Maples, W. J., O'Dorisio, T. M., Warner, R. R. P., Wiseman, G. A., Benson, A. B., & Pommier, R. F. (2010) · Pancreas · doi:10.1097/mpa.0b013e3181ec1261 · Cited by 276
Self-citationYao, J. C., Pavel, M., Lombard-Bohas, C., Van Cutsem, E., Voi, M., Brandt, U., He, W., Chen, D., Capdevila, J., de Vries, E. G. E., et al. (2016) · Journal of Clinical Oncology · doi:10.1200/jco.2016.68.0702 · Cited by 274
Lee, L. C., Grant, C. S., Salomao, D. R., Fletcher, J. G., Takahashi, N., Fidler, J. L., Levy, M. J., & Huebner, M. (2012) · Surgery · doi:10.1016/j.surg.2012.08.038 · Cited by 269
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
O’Toole, D., Grossman, A., Gross, D., Delle Fave, G., Barkmanova, J., O’Connor, J., Pape, U.-F., & Plöckinger, U. (2009) · Neuroendocrinology · doi:10.1159/000225948 · Cited by 268
LIVER TRANSPLANTATION FOR METASTATIC NEUROENDOCRINE CARCINOMA: An Analysis of 103 Patients
Lehnert, T. (1998) · Transplantation · doi:10.1097/00007890-199811270-00007 · Cited by 268
Arnold, R., Rinke, A., Klose, K.-J., Müller, H.-H., Wied, M., Zamzow, K., Schmidt, C., Schade-Brittinger, C., Barth, P., Moll, R., et al. (2005) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(05)00481-7 · Cited by 254
Fine, R. L., Gulati, A. P., Krantz, B. A., Moss, R. A., Schreibman, S., Tsushima, D. A., Mowatt, K. B., Dinnen, R. D., Mao, Y., Stevens, P. D., et al. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2055-z · Cited by 253
Singhi, A. D., Liu, T.-C., Roncaioli, J. L., Cao, D., Zeh, H. J., Zureikat, A. H., Tsung, A., Marsh, J. W., Lee, K. K., Hogg, M. E., et al. (2017) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1113 · Cited by 250
Chromogranin A: is it a useful marker of neuroendocrine tumors?
Campana, D., Nori, F., Piscitelli, L., Morselli-Labate, A. M., Pezzilli, R., Corinaldesi, R., & Tomassetti, P. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2006.10.1535 · Cited by 248
Koopmans, K. P., Neels, O. C., Kema, I. P., Elsinga, P. H., Sluiter, W. J., Vanghillewe, K., Brouwers, A. H., Jager, P. L., & de Vries, E. G. E. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.15.1126 · Cited by 238
Zollinger–Ellison Syndrome: Current Concepts in Diagnosis and Management
Wolfe, M. M., & Jensen, R. T. (1987) · New England Journal of Medicine · doi:10.1056/nejm198711053171907 · Cited by 233
Rhee, T. K., Lewandowski, R. J., Liu, D. M., Mulcahy, M. F., Takahashi, G., Hansen, P. D., Benson, A. B., Kennedy, A. S., Omary, R. A., & Salem, R. (2008) · Annals of Surgery · doi:10.1097/sla.0b013e3181728a45 · Cited by 233
Yao, J. C., Pavel, M., Phan, A. T., Kulke, M. H., Hoosen, S., St. Peter, J., Cherfi, A., & Öberg, K. E. (2011) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-0666 · Cited by 225
Kölby, L., Persson, G., Franzén, S., & Ahrén, B. (2003) · British Journal of Surgery · doi:10.1002/bjs.4149 · Cited by 222
Genome-Wide Analysis of Menin Binding Provides Insights into MEN1 Tumorigenesis
Scacheri, P. C., Davis, S., Odom, D. T., Crawford, G. E., Perkins, S., Halawi, M. J., Agarwal, S. K., Marx, S. J., Spiegel, A. M., Meltzer, P. S., et al. (2006) · PLoS Genetics · doi:10.1371/journal.pgen.0020051 · Cited by 221
The Long-Term Benefit of Liver Transplantation for Hepatic Metastases From Neuroendocrine Tumors
Mazzaferro, V, Sposito, C., Coppa, J., Miceli, R., Bhoori, S., Bongini, M., Camerini, T., Milione, M., Regalia, E., Spreafico, C., et al. (2016) · American Journal of Transplantation · doi:10.1111/ajt.13831 · Cited by 220
Sadanandam, A., Wullschleger, S., Lyssiotis, C. A., Grötzinger, C., Barbi, S., Bersani, S., Körner, J., Wafy, I., Mafficini, A., Lawlor, R. T., et al. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0068 · Cited by 207
Ruszniewski, P., Ducreux, M., Chayvialle, J. A., Blumberg, J., Cloarec, D., Michel, H., Raymond, J. M., Dupas, J. L., Gouerou, H., Jian, R., et al. (1996) · Gut · doi:10.1136/gut.39.2.279 · Cited by 206
Janson, E. T., & Öberg, K. (1993) · Acta Oncologica · doi:10.3109/02841869309083916 · Cited by 204
The glucagonoma syndrome and necrolytic migratory erythema: a clinical review
van Beek, A., de Haas, E., van Vloten, W., Lips, C., Roijers, J., & Canninga-van Dijk, M. (2004) · European Journal of Endocrinology · doi:10.1530/eje.0.1510531 · Cited by 202
Kaltsas, G., Caplin, M., Davies, P., Ferone, D., Garcia-Carbonero, R., Grozinsky-Glasberg, S., Hörsch, D., Tiensuu Janson, E., Kianmanesh, R., Kos-Kudla, B., et al. (2017) · Neuroendocrinology · doi:10.1159/000461583 · Cited by 199
Are Patients with Multiple Endocrine Neoplasia Type I Prone to Premature Death?
Dean, P. G., van Heerden, J. A., Farley, D. R., Thompson, G. B., Grant, C. S., Harmsen, W. S., & Ilstrup, D. M. (2000) · World Journal of Surgery · doi:10.1007/s002680010237 · Cited by 194
Faivre, S., Niccoli, P., Castellano, D., Valle, J. W., Hammel, P., Raoul, J.-L., Vinik, A., Van Cutsem, E., Bang, Y.-J., Lee, S.-H., et al. (2017) · Annals of Oncology · doi:10.1093/annonc/mdw561 · Cited by 194
SPECT/CT hybrid imaging with 111In‐pentetreotide in assessment of neuroendocrine tumours
Krausz, Y., Keidar, Z., Kogan, I., Even‐Sapir, E., Bar‐Shalom, R., Engel, A., Rubinstein, R., Sachs, J., Bocher, M., Agranovicz, S., et al. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01885.x · Cited by 192
Motor Dysfunction of the Small Bowel and Colon in Patients with the Carcinoid Syndrome and Diarrhea
Ohe, M. R. V. D., Camilleri, M., Kvols, L. K., & Thomforde, G. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199310073291503 · Cited by 189
Le Treut, Y. P., Grégoire, E., Belghiti, J., Boillot, O., Soubrane, O., Mantion, G., Cherqui, D., Castaing, D., Ruszniewski, P., Wolf, P., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02233.x · Cited by 189
Berna, M. J., Hoffmann, K. M., Long, S. H., Serrano, J., Gibril, F., & Jensen, R. T. (2006) · Medicine · doi:10.1097/md.0b013e31802b518c · Cited by 188
Khashab, M. A., Yong, E., Lennon, A. M., Shin, E. J., Amateau, S., Hruban, R. H., Olino, K., Giday, S., Fishman, E. K., Wolfgang, C. L., et al. (2011) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2010.08.030 · Cited by 186
Hirschowitz, B., Griffith, J., Pellegrin, D., & Cummings, O. (1992) · Gastroenterology · doi:10.1016/0016-5085(92)70044-c · Cited by 185
Role of neuropeptides and serotonin in the diagnosis of carcinoid tumors
Feldman, J. M., & O'dorisio, T. M. (1986) · The American Journal of Medicine · doi:10.1016/0002-9343(86)90583-8 · Cited by 184
Kulke, M. H., Benson, A. B., Bergsland, E., Berlin, J. D., Blaszkowsky, L. S., Choti, M. A., Clark, O. H., Doherty, G. M., Eason, J., Emerson, L., et al. (2012) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2012.0075 · Cited by 182
Self-citationStrosberg, J. R., Weber, J. M., Feldman, M., Coppola, D., Meredith, K., & Kvols, L. K. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.5924 · Cited by 179
Self-citationNeuroendocrine tumor disease: an evolving landscape
Frilling, A., Åkerström, G., Falconi, M., Pavel, M., Ramos, J., Kidd, M., & Modlin, I. M. (2012) · Endocrine-Related Cancer · doi:10.1530/erc-12-0024 · Cited by 178
ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Tumors: Biochemical Markers
Oberg, K., Couvelard, A., Delle Fave, G., Gross, D., Grossman, A., Jensen, R. T., Pape, U.-F., Perren, A., Rindi, G., Ruszniewski, P., et al. (2017) · Neuroendocrinology · doi:10.1159/000472254 · Cited by 176
Thompson (1998) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.1998.00307.x · Cited by 173
Whole exome sequencing of insulinoma reveals recurrent T372R mutations in YY1
Cao, Y., Gao, Z., Li, L., Jiang, X., Shan, A., Cai, J., Peng, Y., Li, Y., Jiang, X., Huang, X., et al. (2013) · Nature Communications · doi:10.1038/ncomms3810 · Cited by 172
Transcatheter chemoembolization of progressive carcinoid liver metastasis.
Therasse, E., Breittmayer, F., Roche, A., De Baere, T., Indushekar, S., Ducreux, M., Lasser, P., Elias, D., & Rougier, P. (1993) · Radiology · doi:10.1148/radiology.189.2.7692465 · Cited by 172
Cives, M., Ghayouri, M., Morse, B., Brelsford, M., Black, M., Rizzo, A., Meeker, A., & Strosberg, J. (2016) · Endocrine-Related Cancer · doi:10.1530/erc-16-0147 · Cited by 167
Self-citation(1974) · Medical Journal of Australia · doi:10.5694/j.1326-5377.1974.tb71165.x · Cited by 166
Non-Islet Origin of Pancreatic Islet Cell Tumors
Vortmeyer, A. O., Huang, S., Lubensky, I., & Zhuang, Z. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-031575 · Cited by 166
Yao, J. C., Guthrie, K. A., Moran, C., Strosberg, J. R., Kulke, M. H., Chan, J. A., LoConte, N., McWilliams, R. R., Wolin, E. M., Mattar, B., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2016.70.4072 · Cited by 166
Self-citationMoertel, C. G., Rubin, J., & Kvols, L. K. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.7.865 · Cited by 165
The Epidemiology of Neuroendocrine Tumors in Taiwan: A Nation-Wide Cancer Registry-Based Study
Tsai, H.-J., Wu, C.-C., Tsai, C.-R., Lin, S.-F., Chen, L.-T., & Chang, J. S. (2013) · PLoS ONE · doi:10.1371/journal.pone.0062487 · Cited by 163
Molecular Pathology of the MEN1 Gene
AGARWAL, S. K., LEE BURNS, A., SUKHODOLETS, K. E., KENNEDY, P. A., OBUNGU, V. H., HICKMAN, A. B., MULLENDORE, M. E., WHITTEN, I., SKARULIS, M. C., SIMONDS, W. F., et al. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1294.020 · Cited by 163
Hentic, O., Hammel, P., Couvelard, A., Rebours, V, Zappa, M., Palazzo, M., Maire, F., Goujon, G., Gillet, A., Lévy, P., et al. (2012) · Endocrine-Related Cancer · doi:10.1530/erc-12-0002 · Cited by 162
Surgical treatment of mid‐gut carcinoid tumors
Makridis, C., Öberg, K., Juhlin, C., Rastad, J., Johansson, H., Lörelius, L. E., & Åkerström, G. (1990) · World Journal of Surgery · doi:10.1007/bf01658532 · Cited by 161
Radiofrequency Tissue Ablation Using Cooled Tip for Liver Metastases of Endocrine Tumors
Hellman, P., Ladjevardi, S., Skogseid, B., Åkerström, G., & Elvin, A. (2002) · World Journal of Surgery · doi:10.1007/s00268-002-6663-3 · Cited by 159
Kim, J. Y., Brosnan‐Cashman, J. A., An, S., Kim, S. J., Song, K. B., Kim, M. S., Kim, M.-J., Hwang, D. W., Meeker, A. K., Yu, E., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-1147 · Cited by 156
Survival and Prognostic Factor Analysis of 146 Metastatic Neuroendocrine Tumors of the Mid-Gut
Strosberg, J., Gardner, N. M., & Kvols, L. K. (2009) · Neuroendocrinology · doi:10.1159/000197899 · Cited by 151
Self-citationGenetic and epigenetic drivers of neuroendocrine tumours (NET)
Domenico, A. D., Wiedmer, T., Marinoni, I., & Perren, A. A. (2017) · Endocrine Related Cancer · doi:10.1530/erc-17-0012 · Cited by 148
Lack of Benefit from Cervical Cord Stimulation for Dystonia
Kvols, L. K., Martin, J. K., Marsh, H. W., & Moertel, C. G. (1985) · New England Journal of Medicine · doi:10.1056/nejm198511073131915 · Cited by 146
Rectal and colonic carcinoids. A clinicopathologic study of 84 cases
Federspiel, B., BURKE, A. P., Sobin, L. H., & Shekitka, K. M. (1990) · Cancer · doi:10.1002/1097-0142(19900101)65:1<135::aid-cncr2820650127>3.0.co;2-a · Cited by 143
Radionuclide Therapy for Neuroendocrine Tumors
Cives, M., & Strosberg, J. (2017) · Current Oncology Reports · doi:10.1007/s11912-017-0567-8 · Cited by 142
Self-citationBiochemical Testing for Neuroendocrine Tumors
Vinik, A. I., Silva, M. P., Woltering, G., Go, V. L. W., Warner, R., & Caplin, M. E. (2009) · Pancreas · doi:10.1097/mpa.0b013e3181bc0e77 · Cited by 138
Ter‐Minassian, M., Chan, J. A., Hooshmand, S. M., Brais, L. K., Daskalova, A., Heafield, R., Buchanan, L., Qian, Z. R., Fuchs, C. S., Lin, X., et al. (2013) · Endocrine Related Cancer · doi:10.1530/erc-12-0340 · Cited by 132
Peptide Receptor Radionuclide Therapy in the Treatment of Neuroendocrine Tumors
Kwekkeboom, D. J., & Krenning, E. P. (2015) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2015.09.009 · Cited by 131
Klöppel, G., Heitz, P. U., Capella, C., & Solcia, E. (1996) · World Journal of Surgery · doi:10.1007/s002689900021 · Cited by 128
Pavel, M. E., Baudin, É., Öberg, K. E., Hainsworth, J. D., Voi, M., Rouyrre, N., Peeters, M., Gross, D. J., & Yao, J. (2017) · Annals of Oncology · doi:10.1093/annonc/mdx193 · Cited by 128
Surgical Management of Left-Sided Carcinoid Heart Disease
Connolly, H. M., Schaff, H. V., Mullany, C. J., Rubin, J., Abel, M., & Pellikka, P. A. (2001) · Circulation · doi:10.1161/hc37t1.094898 · Cited by 125
Are neuroendocrine tumours a feature of tuberous sclerosis? A systematic review
Dworakowska, D., & Grossman, A. B. (2008) · Endocrine Related Cancer · doi:10.1677/erc-08-0142 · Cited by 125
van Essen, M., Krenning, E. P., Kam, B. L. R., de Herder, W. W., Feelders, R. A., & Kwekkeboom, D. J. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.068957 · Cited by 123
Antiproliferative effect of somatostatin analogs in gastroenteropancreatic neuroendocrine tumors
Strosberg, J., & Kvols, L. (2010) · World Journal of Gastroenterology · doi:10.3748/wjg.v16.i24.2963 · Cited by 121
Self-citationVijayvergia, N., Boland, P. M., Handorf, E. A., Gustafson, K. S., Gong, Y., Cooper, H. S., Sheriff, F. S., Astsaturov, I. A., Cohen, S. J., & Engstrom, P. F. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.229 · Cited by 119
Kulke, M. H., Freed, E., Chiang, D. Y., Philips, J., Zahrieh, D., Glickman, J. N., & Shivdasani, R. A. (2008) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20561 · Cited by 116
Daskalakis, K., Karakatsanis, A., Hessman, O., Stuart, H., Welin, S., Janson, E. T., Öberg, K., Hellman, P., Norlén, O., & Stalberg, P. L. H. (2017) · JAMA Oncology · doi:10.1001/jamaoncol.2017.3326 · Cited by 115
Parenchyma-Sparing Resections for Pancreatic Neuroendocrine Tumors
Cherif, R., Gaujoux, S., Couvelard, A., Dokmak, S., Vuillerme, M.-P., Ruszniewski, P. B., Belghiti, J., & Sauvanet, A. (2012) · Journal of Gastrointestinal Surgery · doi:10.1007/s11605-012-2002-7 · Cited by 114
MGMT expression predicts response to temozolomide in pancreatic neuroendocrine tumors
Cros, J. F., Hentic, O., Rebours, V., Zappa, M., Gille, N., Théou–Anton, N., Vernerey, D., Maire, F., Lévy, P., Bédossa, P., et al. (2016) · Endocrine Related Cancer · doi:10.1530/erc-16-0117 · Cited by 112
Endocrine tumours of the stomach
Fave, G. D., Capurso, G., Milione, M., & Panzuto, F. (2005) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2005.05.002 · Cited by 110
Prognostic Significance of MTOR Pathway Component Expression in Neuroendocrine Tumors
Qian, Z. R., Ter‐Minassian, M., Chan, J. A.-W., Imamura, Y., Hooshmand, S. M., Kuchiba, A., Morikawa, T., Brais, L. K., Daskalova, A., Heafield, R., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.46.6946 · Cited by 110
Massimino, K. P., Harrskog, O., Pommier, S. J., & Pommier, R. F. (2013) · Journal of Surgical Oncology · doi:10.1002/jso.23323 · Cited by 109
Malignant pancreatic tumour within the spectrum of tuberous sclerosis complex in childhood
Verhoef, S., van Diemen-Steenvoorde, R., Akkersdijk, W. L., Bax, N. M. A., Ariyürek, Y., Hermans, C. J., van Nieuwenhuizen, O., Nikkels, P. G. J., Lindhout, D., Halley, D. J. J., et al. (1999) · European Journal of Pediatrics · doi:10.1007/s004310051073 · Cited by 109
Strosberg, J., Benson, A. B., Huynh, L. Y., Duh, M. S., Goldman, J. M., Sahai, V., RADEMAKER, A. W., & Kulke, M. H. (2014) · The Oncologist · doi:10.1634/theoncologist.2014-0120 · Cited by 109
Self-citationRecurrence of Pancreatic Neuroendocrine Tumors and Survival Predicted by Ki67
Genc, C., Falconi, M., Partelli, S., Muffatti, F., van Eeden, S., Doglioni, C., Klümpen, H., van Eijck, C. H. J., & van Dijkum, E. J. M. N. (2018) · Annals of Surgical Oncology · doi:10.1245/s10434-018-6518-2 · Cited by 109
Maire, F., Lombard‐Bohas, C., O’Toole, D., Vullierme, M., Rebours, V., Couvelard, A., Pelletier, A.-L., Zappa, M., Pilleul, F., Hentic, O., et al. (2012) · Neuroendocrinology · doi:10.1159/000336941 · Cited by 108
Gastric carcinoids. An immunohistochemical and clinicopathologic study of 104 patients
Thomas, R. M., Baybick, J. H., Elsayed, A. M., & Sobin, L. H. (1994) · Cancer · Cited by 106
Kim, Y. K., Lee, M. W., Lee, W. J., Kim, S. H., Rhim, H., Lim, J. H., Choi, D., Kim, Y., Jang, K. M., Lee, S. J., et al. (2012) · Investigative Radiology · doi:10.1097/rli.0b013e31823a1495 · Cited by 104
90Y–DOTA– D ‐Phe1–Try3– octreotide in therapy of neuroendocrine malignancies
Paganelli, G., Bodei, L., Handkiewicz-Junak, D., Rocca, P. A., Papi, S., Sierra, M. L., Gatti, M., Chinol, M., Bartolomei, M., Fiorenza, M., et al. (2002) · Biopolymers · doi:10.1002/bip.10349 · Cited by 104
Update on gastroenteropancreatic neuroendocrine tumors
Andreasi, V., Partelli, S., Muffatti, F., Manzoni, M. F., Capurso, G., & Falconi, M. (2020) · Digestive and Liver Disease · doi:10.1016/j.dld.2020.08.031 · Cited by 104
Cunningham, J. L., de Ståhl, T. D., Sjöblom, T., Westin, G., Dumanski, J. P., & Janson, E. T. (2010) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20834 · Cited by 101
Rapid Reversal of Carcinoid Crisis with a Somatostatin Analogue
(1985) · New England Journal of Medicine · doi:10.1056/nejm198511073131916 · Cited by 99
Crona, J., Gustavsson, T., Norlén, O., Edfeldt, K., Åkerström, T., Westin, G., Hellman, P., Björklund, P., & Stalberg, P. L. H. (2015) · Annals of Surgical Oncology · doi:10.1245/s10434-014-4351-9 · Cited by 93
Clinical Management of Gastric Carcinoid Tumors
Ahlman, H., Kölby, L., Lundell, L., et al. (2009) · Digestion · doi:10.1159/000201206 · Cited by 93
Öberg, K., Casanovas, O., Castano, J. P., Chung, D. C., Fave, G. D., Denèfle, P., Harris, P. A., Khan, M. S., Kulke, M. H., Scarpa, A., et al. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-3458 · Cited by 92
Metz, D. C., Strader, D. B., Orbuch, M., Koviack, P. D., Feigenbaum, K. M., & Jensen, R. T. (1993) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.1993.tb00140.x · Cited by 91
Effect of proton-pump inhibitor therapy on serum chromogranin A level.
Pregun, I., Herszényi, L., Juhász, M., Miheller, P., Hritz, I., Patócs, A., Rácz, K., & Tulassay, Z. (2011) · Digestion · doi:10.1159/000321535 · Cited by 89
Asa, S. L. (2011) · Modern Pathology · doi:10.1038/modpathol.2010.127 · Cited by 89
Treatment of Gastric Neuroendocrine Tumors
Schindl, M. (2001) · Archives of Surgery · doi:10.1001/archsurg.136.1.49 · Cited by 89
Alexander, E. K., Robinson, M., Staniec, M., & Dluhy, R. G. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01660.x · Cited by 87
Condron, M. E., Pommier, S. J., & Pommier, R. F. (2015) · Surgery · doi:10.1016/j.surg.2015.05.036 · Cited by 86
Kema, I. P., Schellings, A. M., Meiborg, G., Hoppenbrouwers, C. J. M., & Muskiet, F. A. J. (1992) · Clinical Chemistry · doi:10.1093/clinchem/38.9.1730 · Cited by 84
Adaway, J., Dobson, R., Walsh, J., et al. (2015) · Annals of Clinical Biochemistry International Journal of Laboratory Medicine · doi:10.1177/0004563215613109 · Cited by 78
Raines, D. L., Chester, M. M., Diebold, A. E., Mamikunian, P., ANTHONY, C. T., Mamikunian, G., & Woltering, E. A. (2012) · Pancreas · doi:10.1097/mpa.0b013e318243a0b6 · Cited by 78
Management of functional neuroendocrine tumors of the pancreas.
Öberg, K. (2018) · Gland surgery · doi:10.21037/gs.2017.10.08 · Cited by 78
Mesenteric angiopathy, intestinal gangrene, and midgut carcinoids.
Eckhauser, F. E., Argenta, L. C., Strodel, W. E., et al. (1981) · PubMed · Cited by 70
Intraarterial calcium stimulation test for detection of insulinomas
Doppman, J. L., MILLER, D. L., Chang, R., Görden, P., Eastman, R. C., & Norton, J. A. (1993) · World Journal of Surgery · doi:10.1007/bf01655101 · Cited by 68
Boyce, M. J., Moore, A. R., Sagatun, L., Parsons, B. N., Varró, A., Campbell, F., Fossmark, R., Waldum, H. L., & Pritchard, D. M. (2016) · British Journal of Clinical Pharmacology · doi:10.1111/bcp.13146 · Cited by 68
Cited by
Strosberg, J. R., Caplin, M. E., Kunz, P. L., Ruszniewski, P. B., Bodei, L., Hendifar, A., Mittra, E., Wolin, E. M., Yao, J. C., Pavel, M. E., et al. (2021) · The Lancet Oncology · doi:10.1016/s1470-2045(21)00572-6 · Cited by 578
Self-citationCurrent advance of nanotechnology in diagnosis and treatment for malignant tumors
Wang, B., Hu, S., Teng, Y., Chen, J., Wang, H., Xu, Y., Wang, K., Xu, J., Cheng, Y., & Gao, X. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01889-y · Cited by 558
Multidisciplinary standards of care and recent progress in pancreatic ductal adenocarcinoma
Grossberg, A. J., Chu, L. C., Deig, C. R., Fishman, E. K., Hwang, W. L., Maitra, A., Marks, D. L., Mehta, A., Nabavizadeh, N., Simeone, D. M., et al. (2020) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21626 · Cited by 489
Epidemiology, Incidence, and Prevalence of Neuroendocrine Neoplasms: Are There Global Differences?
Das, S., & Dasari, A. (2021) · Current Oncology Reports · doi:10.1007/s11912-021-01029-7 · Cited by 391
Molecular alterations and targeted therapy in pancreatic ductal adenocarcinoma
Qian, Y., Gong, Y., Fan, Z., Luo, G., Huang, Q., Deng, S., Cheng, H., Jin, K., Ni, Q., Yu, X., et al. (2020) · Journal of Hematology & Oncology · doi:10.1186/s13045-020-00958-3 · Cited by 312
Metadata
- Authors
- Cives, M., & Strosberg, J. R.
- Venue
- CA: A Cancer Journal for Clinicians
- Publisher
- Wiley
- Published
- 2018-10-08
- Volume
- 68
- Issue
- 6
- Pages
- 471-487
- ISSN
- 0007-9235 (ISSN-L)
- 1542-4863
- OpenAlex
- W2896748530
- Cited by
- 586
- References
- 227
- FWCI
- 32.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.